ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Metabolism >Factor Xa inhibitor >Edoxaban (tosylate Monohydrate)

Edoxaban (tosylate Monohydrate)

Edoxaban (tosylate Monohydrate) Structure
CAS No.
1229194-11-9
Chemical Name:
Edoxaban (tosylate Monohydrate)
Synonyms
Edoxaban tosilate;edoxaban tosylate hydrate;Edoxaban Tosilate Monohydrate;Lixiana;Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate;CS-1597;Yidu Saban Mesylate;Edoxaban Tosylate Hydrate 1;Etuxaban p-toluenesulfonate;Edoxaban (TsOH salt hydrate)
CBNumber:
CB82645582
Molecular Formula:
C31H38ClN7O7S2
Molecular Weight:
720.26
MOL File:
1229194-11-9.mol
MSDS File:
SDS
Modify Date:
2024/7/3 13:03:20

Edoxaban (tosylate Monohydrate) Properties

Melting point >252°C (dec.)
storage temp. Hygroscopic, Refrigerator, under inert atmosphere
solubility Chloroform (Very Slightly), DMSO (Slightly), Methanol (Slightly, Sonicated)
form Solid
color White to Off-White
Stability Hygroscopic
InChIKey ZLFZITWZOYXXAW-BUZWFPPCNA-N
SMILES S(C1C=CC(C)=CC=1)(O)(=O)=O.N([C@@H]1C[C@@H](C(=O)N(C)C)CC[C@@H]1NC(=O)C(=O)NC1N=CC(Cl)=CC=1)C(C1SC2CN(C)CCC=2N=1)=O |&1:12,14,22,r|

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338

Edoxaban (tosylate Monohydrate) Chemical Properties,Uses,Production

Uses

Edoxaban is an anticoagulant drug which acts as a direct factor Xa inhibitor.

Definition

ChEBI: A hydrate that is the monohydrate of the tosylate salt of edoxaban. Used for the treatment of deep vein thrombosis and pulmonary embolism.

Clinical Use

Daichi Sankyo’s edoxaban tosilate is an orally administered coagulation factor Xa inhibitor that was approved and launched in Japan for the preventive treatment of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty, total hip arthroplasty, or hip fracture surgery. Edoxaban has been shown to have a rapid onset of anticoagulant effect due to short Tmax (1–2 h) after dosing and sustained for up to 24 h post-dose. Marketed under the brand name Lixiana, it is currently in phase III studies in the US for the prevention of stroke and systemic embolic events in patients with atrial fibrillation (AF) and venous thromboembolism (VTE).

Edoxaban (tosylate Monohydrate) Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 250)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Mehta API Pvt. Ltd. +91-9920552082 +91-9920552082 Maharashtra, India 33 58 Inquiry
CVR Life sciences Pvt Ltd +91-7386789224 +91-9912960099 Hyderabad, India 22 58 Inquiry
Metrochem API Private Limited +91-4069069999 +91-4069069999 Telangana, India 78 58 Inquiry
Honour Lab Limited +919845977466 Telangana, India 164 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
CADILA HEALTHCARE LTD +91 2718 225001 New Delhi, India 110 58 Inquiry
HONOUR LAB LTD +91-40-23710405 New Delhi, India 39 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry

Edoxaban (tosylate Monohydrate) Spectrum

Edoxaban (tosylate Monohydrate) Edoxaban p-toluenesulfonate monohydrate N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-[(dimethyl amino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-toluenesulfonate monohydrate N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide 4-methylbenzenesulfonate hydrate Edoxaban Tosylate Hydrate 1 Edoxaban (TsOH salt hydrate) CS-1597 Edoxaban tosylate monohydrate(for Edoxaban) DU-176b tosylate Monohydrate Edoxaban (tosylate Monohydrate) USP/EP/BP Edoxaban tosylate monohydrate (DU-176b) Edoxaban tosilate Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-, 4-methylbenzenesulfonate, hydrate edoxaban tosylate hydrate Edoxaban Tosilate Monohydrate Lixiana Idoseban p-Toluenesulfonate Monohydrate Edoxaban Impurity 34 p-Toluenesulfonate Salt Monohydrate Edoxaban Impurity 29 p-Toluenesulfonate Salt Etuxaban p-toluenesulfonate Yidu Saban Mesylate 1229194-11-9 C24H30ClN7O4SC7H8O3SH2O C31H40ClN7O8S2 Inhibitors API